Impact of Positron Emission Tomography (PET) with 18F-Fluciclovine on Management of Patients with Recurrence of Prostate Cancer: Results from the Falcon Trial

Early and accurate localization of recurrent and metastatic lesions in men with biochemical recurrence (BCR) of prostate cancer may guide decisions regarding salvage therapy. The present study, FALCON, aimed to confirm the clinical benefit of PET with 18F-fluciclovine through its impact on management decisions for men with BCR of prostate cancer. Men (≥18 years, ECOG 0–2) with a first episode of BCR who were being considered for radical salvage...